UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

Journal of clinical oncology, 2012-02, Vol.30 (4), p.372-379

2012

Volltextzugriff (PDF)

Energy-Efficient Through-Life Smart Design, Manufacturing and Operation of Ships in an Industry 4.0 Environment

Energies (Basel), 2017, Vol.10 (5), p.610

2017

Volltextzugriff (PDF)

Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer

European radiology, 2021-06, Vol.31 (6), p.3765-3772

2021

Volltextzugriff (PDF)

Elevated procalcitonin levels in anaphylaxis

Hong Kong journal of emergency medicine, 2020-07, Vol.27 (4), p.241-244

Joo Shiang, Ang

2020

Volltextzugriff (PDF)

Non-contrast MRI can accurately characterize adnexal masses: a retrospective study

European radiology, 2021-09, Vol.31 (9), p.6962-6973

2021

Volltextzugriff (PDF)

Unusual appearance of air in soft tissue on ultrasound

Clinical and experimental emergency medicine, 2022-12, Vol.9 (4), p.380-382

Ang, Joo Shiang

2022

Volltextzugriff (PDF)

Effect of sleep deprivation on the human metabolome

Proceedings of the National Academy of Sciences - PNAS, 2014-07, Vol.111 (29), p.10761-10766

2014

Volltextzugriff (PDF)

Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Molecular cancer therapeutics, 2016-06, Vol.15 (6), p.1412-1424

2016

Volltextzugriff (PDF)

Tissue-based approaches to study pharmacodynamic endpoints in early phase oncology clinical trials

Current drug targets, 2012-11, Vol.13 (12), p.1525-1534

2012

Volltextzugriff (PDF)

Advancing multiproduct resin reuse for development and clinical manufacturing of an antibody‐based therapeutic

Biotechnology progress, 2024-05, Vol.40 (3), p.e3434-n/a

2024

Volltextzugriff (PDF)

Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials

Journal of clinical oncology, 2009-06, Vol.27 (16), p.2692-2696

2009

Volltextzugriff (PDF)

Efficacy of Chemotherapy in BRCA1/2 Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study

Clinical cancer research, 2013-10, Vol.19 (19), p.5485-5493

2013

Volltextzugriff (PDF)

Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1)

Investigational new drugs, 2020-08, Vol.38 (4), p.1117-1128

2020

Volltextzugriff (PDF)

Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer

Oncotarget, 2017-07, Vol.8 (29), p.47154-47160

2017

Volltextzugriff (PDF)

Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2)

Investigational new drugs, 2020-08, Vol.38 (4), p.1096-1107

2020

Volltextzugriff (PDF)

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Molecular cancer therapeutics, 2017-10, Vol.16 (10), p.2315-2323

2017

Volltextzugriff (PDF)

Identification of Human Plasma Metabolites Exhibiting Time-of-Day Variation Using an Untargeted Liquid Chromatography-Mass Spectrometry Metabolomic Approach

Chronobiology international, 2012-08, Vol.29 (7), p.868-881

2012

Volltextzugriff (PDF)

Radiological Patterns of Drug-induced Interstitial Lung Disease (DILD) in Early-phase Oncology Clinical Trials

Clinical cancer research, 2020-09, Vol.26 (18), p.4805-4813

2020

Volltextzugriff (PDF)

Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study

Clinical colorectal cancer, 2018-03, Vol.17 (1), p.e69-e76

2018

Volltextzugriff (PDF)

Gastric outlet obstruction: not to be missed on ultrasound

Internal and emergency medicine, 2023-09, Vol.18 (6), p.1863-1864

Ang, Joo Shiang

2023

Volltextzugriff (PDF)

Rule-Based Control Studies of LNG–Battery Hybrid Tugboat

Journal of marine science and engineering, 2023-07, Vol.11 (7), p.1307

2023

Volltextzugriff (PDF)

First-in-human, Pharmacokinetic and Pharmacodynamic Phase I Study of Resminostat, an Oral Histone Deacetylase Inhibitor, in Patients with Advanced Solid Tumors

Clinical cancer research, 2013-10, Vol.19 (19), p.5494-5504

2013

Volltextzugriff (PDF)

Development of an Automatic Analysis Methodology by Integration of Digital Hull Design, Model, Processing, and Evaluation

Journal of physics. Conference series, 2019-10, Vol.1357 (1), p.12003

2019

Volltextzugriff (PDF)

Use of STONE Score to Predict Urolithiasis in an Asian Emergency Department

Journal of Acute Medicine, 2022-06, Vol.12 (2), p.53-59

2022

Volltextzugriff (PDF)

Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity

Radiology, 2012-11, Vol.265 (2), p.426-436

2012

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

Energy-Efficient Through-Life Smart Design, Manufacturing and Operation of Ships in an Industry 4.0 Environment

Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer

Elevated procalcitonin levels in anaphylaxis

Non-contrast MRI can accurately characterize adnexal masses: a retrospective study

Unusual appearance of air in soft tissue on ultrasound

Effect of sleep deprivation on the human metabolome

Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Tissue-based approaches to study pharmacodynamic endpoints in early phase oncology clinical trials

Advancing multiproduct resin reuse for development and clinical manufacturing of an antibody‐based therapeutic

Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials

Efficacy of Chemotherapy in BRCA1/2 Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study

Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1)

Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer

Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2)

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Identification of Human Plasma Metabolites Exhibiting Time-of-Day Variation Using an Untargeted Liquid Chromatography-Mass Spectrometry Metabolomic Approach

Radiological Patterns of Drug-induced Interstitial Lung Disease (DILD) in Early-phase Oncology Clinical Trials

Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study

Gastric outlet obstruction: not to be missed on ultrasound

Rule-Based Control Studies of LNG–Battery Hybrid Tugboat

First-in-human, Pharmacokinetic and Pharmacodynamic Phase I Study of Resminostat, an Oral Histone Deacetylase Inhibitor, in Patients with Advanced Solid Tumors

Development of an Automatic Analysis Methodology by Integration of Digital Hull Design, Model, Processing, and Evaluation

Use of STONE Score to Predict Urolithiasis in an Asian Emergency Department

Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity

Suchergebnisse filtern